Skip to content
Toggle main navigation
Opto.Edcelerate logo
Opto.Edcelerate logo
      Log in
      Community engagement platform by Hivebrite.

      News

      All
      Amanda Dexter
      News Feed
      Short Articles
      Talin Amadian

      Results (4081)

      EyePoint Names Tarek S. Hassan, MD, as SVP and Chief Strategic Science Officer

      EyePoint Names Tarek S. Hassan, MD, as SVP and Chief Strategic Science Officer

      WATERTOWN, Mass.—EyePoint, Inc. (Nasdaq: EYPT), a clinical-stage biopharmaceutical company and developer of therapeutics for patients with serious retinal diseases, has announced the appointment of Tarek S. Hassan, MD, as senior vice president, chief strategic science officer. Dr. Hassan will report directly to Jay S. Duker, MD, president and CEO of EyePoint, and will serve as a member of the exec
      July 14, 2026
      Tenpoint Therapeutics Seeks Regulatory UK Approval for Yuvezzi, Presbyopia Treatment

      Tenpoint Therapeutics Seeks Regulatory UK Approval for Yuvezzi, Presbyopia Treatment

      LONDON and WARREN, N.J.,—Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic pharmaceutical company focused on developing treatments to improve vision in the aging eye, has submitted a marketing authorization application (MAA) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for the review and approval of Yuvezzi (carbachol and brimonidine tartrate o
      July 14, 2026
      American Foundation for the Blind Announces 2026 Kirchner and Gund Award Honorees

      American Foundation for the Blind Announces 2026 Kirchner and Gund Award Honorees

      WASHINGTON, D.C.—The American Foundation for the Blind (AFB) has announced the 2026 recipients of its Corinne Kirchner Research Award and Llura Gund Leadership Award. The Corinne Kirchner Research Award will be presented to Rachel Schles, Ph.D., assistant professor at Vanderbilt University; the Llura Gund Leadership Award will be presented to Marissa Miara, director of student services at Marshall
      July 14, 2026
      KeraLink International Provides 2026 Q2 Update on Programs, Partnerships

      KeraLink International Provides 2026 Q2 Update on Programs, Partnerships

      BALTIMORE—KeraLink International (KLI), a 501(c)(3) nonprofit dedicated to making vision care affordable and accessible, announced that as the second quarter of 2026 closes, the group continues to build steady momentum across clinical training, innovation, and mission-aligned partnerships. The announcement highlighted that Q2 reinforced a singular focus on converting progress into quantifiable adv
      July 14, 2026
      GLP-1 Drugs Linked to Increased Risk of Periorbital Changes, Study Finds

      GLP-1 Drugs Linked to Increased Risk of Periorbital Changes, Study Finds

      The rapid weight reduction triggered by GLP-1 therapy has numerous health benefits, of course. However, an oculoplastics team from Bascom Palmer found that the ensuing loss of subcutaneous fat can lead to visually unwanted periorbital changes. Photo: Mary E. Boname, OD. Click image to enlarge. A study published in Ophthalmic Plastic and Reconstructive Surge
      July 14, 2026
      30 years in Maghull

      30 years in Maghull

      Nikki Fenner Optometrist, which opened its doors three decades ago, is celebrating the milestone
      July 13, 2026
      RNIB responds to review that finds PIP payments are “not fit for purpose”

      RNIB responds to review that finds PIP payments are “not fit for purpose”

      A comprehensive review of personal independence payments has heard from claimants who find the assessment process “dehumanising and stressful”
      July 13, 2026
      Cardiff University and Newmedica partner for training development

      Cardiff University and Newmedica partner for training development

      The partners will seek to provide enhanced training in secondary eye care roles
      July 13, 2026
      The National Average for Gross Revenue at ECP Locations Increased for the Month of June, Jobson’s Latest Practice Performance Tracker Shows

      The National Average for Gross Revenue at ECP Locations Increased for the Month of June, Jobson’s Latest Practice Performance Tracker Shows

      NEWARK, N.J.—The national average for gross revenue at ECP locations increased last month, June 2026, when compared with the previous month, at a rate of 18 index points. That places gross revenue at a level 7 index points above where it was at this point in time (June) when compared with last year (2025), 23 points above the same period in 2024, 17 points above 2023, 27 points above 2022, 32 poin
      July 13, 2026
      AOA Opens Public Comment, Review Period for Pediatric Eye and Vision Examination Guideline

      AOA Opens Public Comment, Review Period for Pediatric Eye and Vision Examination Guideline

      ST. LOUIS—The American Optometric Association (AOA) announced it has opened the 30-day peer and public review period for the second edition of its evidence-based “Comprehensive Pediatric Eye and Vision Examination” clinical practice guideline. Comments will be accepted through August 5, 2026.
      July 13, 2026
      Contact Lens Institute Now Accepting Nominations for the Culture Awards

      Contact Lens Institute Now Accepting Nominations for the Culture Awards

      WASHINGTON D.C.—Nominations are now being accepted for the fourth annual Contact Lens Institute (CLI) Culture Awards through October 1, 2026. The program honors eyecare professionals who cultivate a positive contact lens culture by demonstrating behaviors that enhance patient experiences and support practice success, as reflected in CLI’s recent See Tomorrow research reports. Individuals within th
      July 13, 2026
      Registration Launches for Upcoming Eye to Eye Las Vegas Conference

      Registration Launches for Upcoming Eye to Eye Las Vegas Conference

      LAS VEGAS—Registration is now open for SECO & AFOS Destination Eye to Eye Las Vegas, which will be held from September 15-20, 2026, at the Paris Las Vegas Hotel and Casino. Eyecare professionals are invited to a week of connection and learning, with the event offering continuing education, expert-led workshops, and collaborative learning opportunities tailored for optometrists, paraoptometrics and
      July 13, 2026
      Weave Earns 2026 USA TODAY Top Workplaces Award

      Weave Earns 2026 USA TODAY Top Workplaces Award

      LEHI, Utah—Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, including a solution-based platform specifically designed for optometry practices, announced that it has earned the prestigious 2026 USA TODAY Top Workplaces award. The award honors organizations with 150 or more employees that have created exceptional, people-first
      July 13, 2026
      Study of Ophthalmology Referrals Finds “Considerable Room for Improvement” in Documentation, but Best Overall Scores for ODs

      Study of Ophthalmology Referrals Finds “Considerable Room for Improvement” in Documentation, but Best Overall Scores for ODs

      A new retrospective study from Canada looked at the case details included (or excluded) when a patient is referred to an ophthalmologist to see if specific patterns emerge by provider type, to test whether referral quality affected triage urgency and to consider how closely the provisional diagnosis at referral matched the final diagnosis. The researchers found, unsurprisingly, that incomplete ref
      July 13, 2026
      Teprotumumab for TED Worsens Glycemic Control

      Teprotumumab for TED Worsens Glycemic Control

      The present study showcased the impact teprotumumab has on glycemic control. It can take several months for patients to return to their baseline HbA1c measurement after presenting with worsening glycemic control. For diabetic patients, it took a median of 13.1 months; for those with prediabetes, it took a median of 7.7 months; and for normoglycemic patients, it took a median of 6.4 months. Photo: 
      July 13, 2026
      Exploring the effect of the US opioid epidemic on endogenous endophthalmitis cases

      Exploring the effect of the US opioid epidemic on endogenous endophthalmitis cases

      Researchers report that the number of drug use-associated endogenous endophthalmitis cases are on the rise
      July 10, 2026
      Nicotinamide Supplementation Associated with Reduced Risk of POAG in Those with OHT

      Nicotinamide Supplementation Associated with Reduced Risk of POAG in Those with OHT

      Systemic nicotinamide may serve as a prophylactic therapy to delay or prevent the onset of POAG, but many questions on clinical guidance still remain. Photo: Bisant Labib, OD. Click image to enlarge. While traditional management of patients with ocular hypertension relies strictly on lowering intraocular pressure (IOP) to delay primary open-angle glaucoma (POAG) onset, a con
      July 10, 2026
      Midyear 2026 recap: Major clinical findings in optometry

      Midyear 2026 recap: Major clinical findings in optometry

      A midyear look at 2026's biggest optometry findings, from myopia control research to safety signals on red light therapy and semaglutide.
      July 10, 2026
      Fielmann Group Releases Preliminary Second Quarter Results, Highlights International Sales Growth, Store Expansion

      Fielmann Group Releases Preliminary Second Quarter Results, Highlights International Sales Growth, Store Expansion

      HAMBURG, Germany—Global eyewear provider Fielmann Group announced preliminary consolidated sales of €1.25 billion for the first half of 2026, marking a 2 percent year-over-year increase from €1.23 billion for the first half of 2025. This growth was supported by a modest expansion in Fielmann Germany and a significant acceleration in international sales, which jumped from 1 percent growth in Q1 to
      July 10, 2026
      Bausch + Lomb Introduces Orphia, an AI-Powered Digital Health Platform

      Bausch + Lomb Introduces Orphia, an AI-Powered Digital Health Platform

      VAUGHAN, Ontario and MENLO PARK, Calif.—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced the creation of Orphia, a brand-agnostic, AI-powered digital health platform designed to support eyecare providers and improve patient education. Orphia will serve all eyecare providers, regardless of the products, devices or treatments they choose to use, and it will operate
      July 10, 2026